The Latin America, Middle East and Africa Ureteral Stents Market would witness market growth of 8.2% CAGR during the forecast period (2023-2030). In the year 2026, the LAMEA market's volume is expected to surge to 1,312.3 thousand units, showcasing a growth of 9.8% (2023-2030).
Integrating technology into ureteral stent design is a burgeoning trend. Smart stents equipped with sensors or imaging capabilities are being explored to provide real-time data on urinary parameters, allowing for more precise monitoring and personalized patient care. Smart stents are designed to provide continuous and real-time monitoring of various urinary parameters. This includes data on urine flow rate, pressure within the ureter, and the presence of any obstructions or irregularities. Collecting real-time data gives healthcare professionals a dynamic and accurate understanding of the patient's urinary status. This data can be crucial in assessing the effectiveness of the stent, identifying complications, and making informed decisions regarding patient care.
Moreover, the evolving landscape of healthcare emphasizes patient-centric approaches. In the market, this translates to developing stents that prioritize patient comfort, reduce side effects, and offer ease of removal. These advancements contribute to improved patient compliance and overall satisfaction. Modern these stents consider patients' comfort during their placement and throughout use. Innovations in stent design aim to reduce irritation, discomfort, and awareness of the stent's presence within the urinary tract. The choice of materials used in stent construction directly impacts patient comfort. Bio-inert and biocompatible materials are being explored to minimize tissue irritation and inflammatory responses.
As per the data provided by the Government of Brazil, between 2012 and 2021, the share of persons aged 60 and over went from 11.3% to 14.7% of the population. In absolute figures, this age group changed from 22.3 million to 31.2 million, with an increase of 39.8%. Therefore, the aging population and increased healthcare spending in major countries of LAMEA are expected to help grow the regional market.
The Brazil market dominated the LAMEA Ureteral Stents Market by Country in 2022, and would continue to be a dominant market till 2030; thereby, achieving a market value of $24.8 million by 2030. The Argentina market is showcasing a CAGR of 8.8% during (2023 - 2030). Additionally, The UAE market would register a CAGR of 7.9% during (2023 - 2030).
Based on End User, the market is segmented into Hospitals, and Ambulatory Surgical Centers (ASCS) & Clinics. Based on Material, the market is segmented into Metallic Stents and Polymer Stents (Silicone Stents, Hybrid Stents, and Polyurethane Stents). Based on Product, the market is segmented into Double Pigtail Stent, Open/Closed Pigtail Stent, and Multiloop Stents. Based on Application, the market is segmented into Kidney Stones, Kidney Transplantation, Urinary Incontinence, Tumors, and Others. Based on countries, the market is segmented into Brazil, Argentina, UAE, Saudi Arabia, South Africa, Nigeria, and Rest of LAMEA.
The market research report covers the analysis of key stake holders of the market. Key companies profiled in the report include Boston Scientific Corporation, B. Braun Melsungen AG, Coloplast Group, Medline Industries, Inc., Allium Ltd, Cook Medical, Inc. (Cook Group), Pnn Medical A/S, Teleflex, Inc., Olympus Corporation and Becton, Dickinson, and Company
Integrating technology into ureteral stent design is a burgeoning trend. Smart stents equipped with sensors or imaging capabilities are being explored to provide real-time data on urinary parameters, allowing for more precise monitoring and personalized patient care. Smart stents are designed to provide continuous and real-time monitoring of various urinary parameters. This includes data on urine flow rate, pressure within the ureter, and the presence of any obstructions or irregularities. Collecting real-time data gives healthcare professionals a dynamic and accurate understanding of the patient's urinary status. This data can be crucial in assessing the effectiveness of the stent, identifying complications, and making informed decisions regarding patient care.
Moreover, the evolving landscape of healthcare emphasizes patient-centric approaches. In the market, this translates to developing stents that prioritize patient comfort, reduce side effects, and offer ease of removal. These advancements contribute to improved patient compliance and overall satisfaction. Modern these stents consider patients' comfort during their placement and throughout use. Innovations in stent design aim to reduce irritation, discomfort, and awareness of the stent's presence within the urinary tract. The choice of materials used in stent construction directly impacts patient comfort. Bio-inert and biocompatible materials are being explored to minimize tissue irritation and inflammatory responses.
As per the data provided by the Government of Brazil, between 2012 and 2021, the share of persons aged 60 and over went from 11.3% to 14.7% of the population. In absolute figures, this age group changed from 22.3 million to 31.2 million, with an increase of 39.8%. Therefore, the aging population and increased healthcare spending in major countries of LAMEA are expected to help grow the regional market.
The Brazil market dominated the LAMEA Ureteral Stents Market by Country in 2022, and would continue to be a dominant market till 2030; thereby, achieving a market value of $24.8 million by 2030. The Argentina market is showcasing a CAGR of 8.8% during (2023 - 2030). Additionally, The UAE market would register a CAGR of 7.9% during (2023 - 2030).
Based on End User, the market is segmented into Hospitals, and Ambulatory Surgical Centers (ASCS) & Clinics. Based on Material, the market is segmented into Metallic Stents and Polymer Stents (Silicone Stents, Hybrid Stents, and Polyurethane Stents). Based on Product, the market is segmented into Double Pigtail Stent, Open/Closed Pigtail Stent, and Multiloop Stents. Based on Application, the market is segmented into Kidney Stones, Kidney Transplantation, Urinary Incontinence, Tumors, and Others. Based on countries, the market is segmented into Brazil, Argentina, UAE, Saudi Arabia, South Africa, Nigeria, and Rest of LAMEA.
The market research report covers the analysis of key stake holders of the market. Key companies profiled in the report include Boston Scientific Corporation, B. Braun Melsungen AG, Coloplast Group, Medline Industries, Inc., Allium Ltd, Cook Medical, Inc. (Cook Group), Pnn Medical A/S, Teleflex, Inc., Olympus Corporation and Becton, Dickinson, and Company
Scope of the Study
Market Segments Covered in the Report:
By End User (Volume, Thousand Units, Revenue, USD Million, 2019-30)- Hospitals
- Ambulatory Surgical Centers (ASCS) & Clinics
- Metallic Stents
- Polymer Stents
- Silicone Ureteral Stents
- Hybrid Ureteral Stents
- Polyurethane Stents
- Double Pigtail Stent
- Open/Closed Pigtail Stent
- Multiloop Stents
- Kidney Stones
- Kidney Transplantation
- Urinary Incontinence
- Tumors
- Others
- Brazil
- Argentina
- UAE
- Saudi Arabia
- South Africa
- Nigeria
- Rest of LAMEA
Key Market Players
List of Companies Profiled in the Report:
- Boston Scientific Corporation
- B.Braun Melsungen AG
- Coloplast Group
- Medline Industries, Inc.
- Allium Ltd
- Cook Medical, Inc. (Cook Group)
- Pnn Medical A/S
- Teleflex, Inc.
- Olympus Corporation
- Becton, Dickinson, and Company
Unique Offerings
- Exhaustive coverage
- The highest number of Market tables and figures
- Subscription-based model available
- Guaranteed best price
- Assured post sales research support with 10% customization free
Table of Contents
Chapter 1. Market Scope & Methodology
Chapter 2. Market At a Glance
Chapter 3. Market Overview
Chapter 4. LAMEA Ureteral Stents Market by End User
Chapter 5. LAMEA Ureteral Stents Market by Material
Chapter 6. LAMEA Ureteral Stents Market by Product
Chapter 7. LAMEA Ureteral Stents Market by Application
Chapter 8. LAMEA Ureteral Stents Market by Country
Chapter 9. Company Profiles
Companies Mentioned
- Boston Scientific Corporation
- B. Braun Melsungen AG
- Coloplast Group
- Medline Industries, Inc.
- Allium Ltd
- Cook Medical, Inc. (Cook Group)
- Pnn Medical A/S
- Teleflex, Inc.
- Olympus Corporation
- Becton, Dickinson, and Company
Methodology
LOADING...
